Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LOXL2 | Q9Y4K0 | 2/20 | 0.52 |
| ▸ | LTA4H | P09960 | 3/20 | 0.51 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.51 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.50 |
| ▸ | NPC1 | O15118 | 2/20 | 0.50 |
| ▸ | RAB9A | P51151 | 2/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
| ▸ | GPR39 | O43194 | 1/20 | 0.50 |
| ▸ | LOX | P28300 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | HTT | P42858 | 1/20 | 0.48 |
| ▸ | TLR4 | O00206 | 1/20 | 0.47 |
| ▸ | TLR2 | O60603 | 1/20 | 0.47 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.46 |
| ▸ | BLM | P54132 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL147539 | 1.00 | LOXL2 (0.52) | LOXL2LTA4HPTGS2CYP1A2NPC1 | |
| SCHEMBL8510667 | 0.98 | LTA4H (0.50) | LOXL2LTA4HPTGS2CYP1A2NPC1 | |
| SCHEMBL5443693 | 0.98 | LTA4H (0.50) | LOXL2LTA4HPTGS2CYP1A2NPC1 | |
| Methyl Alcohol SCHEMBL11157137 | 0.96 | GPR39 (0.51) | LOXL2LTA4HPTGS2CYP1A2NPC1 | |
| SCHEMBL11143982 | 0.93 | PTGS2 (0.57) | LOXL2LTA4HPTGS2CYP1A2NPC1 | |
| SCHEMBL16345487 | 0.92 | LTA4H (0.46) | LOXL2LTA4HPTGS2CYP1A2NPC1 | |
| Formic Acid SCHEMBL27325993 | 0.88 | TLR4 (0.48) | LOXL2LTA4HPTGS2CYP1A2NPC1 | |
| SCHEMBL7916927 | 0.88 | KDM4E (0.46) | LOXL2LTA4HPTGS2CYP1A2NPC1 | |
| SCHEMBL9135525 | 0.87 | KDM4E (0.56) | LOXL2LTA4HPTGS2CYP1A2NPC1 | |
| SCHEMBL28001241 | 0.87 | LTA4H (0.50) | LOXL2LTA4HPTGS2CYP1A2NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12527214-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2026-01-13 | — | — | US | disclosed |
| WO-2025030146-A1 | COMPOUNDS CONTAINING ORGANOMETALIC STABILIZED GOLD (III) MACROCYCLES | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) | 2025-02-06 | — | — | WO | disclosed |
| US-20240397810-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2024-11-28 | — | — | US | disclosed |
| US-20240180886-A1 | INHIBITORS OF PROTEIN TYROSINE PHOSPHATASE, COMPOSITIONS, AND METHODS OF USE | BRISTOL-MYERS SQUIBB COMPANY (US) | 2024-06-06 | — | — | US | disclosed |
| US-11871652-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2024-01-09 | — | — | US | disclosed |
| US-11611042-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2023-03-21 | — | — | US | disclosed |
| US-11495754-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2022-11-08 | — | — | US | disclosed |
| CN-113105475-B | Inhibitors of bruton's tyrosine kinase and methods of use thereof | 詹森药业有限公司 | 2022-09-09 | — | — | CN | disclosed |
| US-11342516-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2022-05-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11342516-B2 | Organic electroluminescent materials and devices | ORC3, OCIAD1, ICOSLG | LOXL2 149/4885LTA4H 1627/4885PTGS2 4244/4885 |
| US-11611042-B2 | Organic electroluminescent materials and devices | OCIAD2, JUND, OCIAD1 | LOXL2 170/4885LTA4H 603/4885PTGS2 2489/4885 |
| US-11495754-B2 | Organic electroluminescent materials and devices | OCIAD2, OCIAD1, EML4 | LOXL2 315/4885LTA4H 2910/4885PTGS2 2739/4885 |
| US-20240180886-A1 | INHIBITORS OF PROTEIN TYROSINE PHOSPHATASE, COMPOSITIONS, AND METHODS OF USE | PTPN2, PTPN22, PTPN1 | LOXL2 715/4885LTA4H 3665/4885PTGS2 2255/4885 |
| US-11871652-B2 | Organic electroluminescent materials and devices | IRS1, L1CAM, TLL2 | LOXL2 395/4885LTA4H 2410/4885PTGS2 4271/4885 |
| US-20240397810-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | ORC3, OCIAD1, ICOSLG | LOXL2 149/4885LTA4H 1627/4885PTGS2 4244/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.